NCT02020902已完成不适用
Contac Bien Z Adverse Effect Survey
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,552
- 试验地点
- 1
- 主要终点
- Adverse events after having cetrizine hydrochloride
研究概览
简要总结
This is a post-marketing surveillance study on a marketed cetrizine hydrochloride formulation.
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 15 Years 至 65 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male and female participants, between 15-65 years of age, who purchase the marketed cetrizine hydrochloride formulation
排除标准
- •Who have ever experienced allergic symptoms by taking this medication or any component of this medication, piperazine derivative (including levocetirizine, hydroxizine)
- •Those who have been under 15en diagnosed with kidney disease
- •Children under 15 years of age
结局指标
主要结局
Adverse events after having cetrizine hydrochloride
时间窗: At baseline
Participants will answer a questionnaire which consists of questions on safety of the marketed cetrizine hydrochloride formulation.
次要结局
- Efficacy of the marketed cetrizine hydrochloride formulation(At baseline)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
An Observational Study of Herceptin SC Safety in Breast CancerBreast CancerNCT02305628Hoffmann-La Roche600
尚未招募
不适用
Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.ImmunizationInfluenza (Healthy Volunteers)NCT06694025Sanofi670
撤回
不适用
A Study on the Safety and Effectiveness of Rilpivirine Hydrochloride (Edurant) Among Adult Filipino Patients With Human Immunodeficiency Virus Type-I InfectionHuman Immunodeficiency Virus Type 1 (HIV-1) InfectionNCT01692470Janssen Pharmaceutica
已完成
不适用
A Study for Post-Marketing Surveillance of Niraparib in the Treatment of Adult Participants for Approved Indications in South KoreaOvarian NeoplasmsNCT04589039Takeda662
已完成
不适用
Non-Interventional Post Marketing Surveillance Study To Observe The Safety And Efficacy Of Vfend® IVSerious Fungal InfectionsNCT01073618Pfizer692